8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors3,588 citations

Tang J, Zhang Y, Yang L, Chen Q, Tan L, Zuo S, Feng H, Chen Z, Zhu G

Bioeffects Seen

Authors not listed · 2015

Share:

Genomic analysis reveals distinct cancer-causing signatures, offering a model for identifying EMF's potential cellular damage patterns.

Plain English Summary

Summary written for general audiences

Researchers analyzed genetic mutations in 279 head and neck cancers to understand what drives these tumors. They found distinct genetic patterns: HPV-related cancers had specific PIK3CA mutations, while smoking-related cancers showed nearly universal TP53 gene damage. The study identified potential therapeutic targets in most cases.

Why This Matters

While this comprehensive genetic analysis of head and neck cancers doesn't directly examine EMF exposure, it reveals something crucial: the molecular fingerprints that different carcinogens leave behind. The near-universal TP53 mutations in smoking-related cancers show how specific exposures create identifiable genetic damage patterns. This matters because we're still in the early stages of understanding what molecular signatures EMF exposure might create in human tissues. The reality is that if radiofrequency radiation does contribute to cancer development, we would expect to see characteristic genetic alterations emerge in exposed populations over time. What this study demonstrates is that modern genomic analysis can definitively identify the cellular mechanisms behind cancer development. As EMF research advances, similar comprehensive genomic studies of tumors in heavily exposed populations could provide the definitive evidence we need to understand EMF's true cancer risk.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2015). Tang J, Zhang Y, Yang L, Chen Q, Tan L, Zuo S, Feng H, Chen Z, Zhu G.
Show BibTeX
@article{tang_j_zhang_y_yang_l_chen_q_tan_l_zuo_s_feng_h_chen_z_zhu_g_ce3518,
  author = {Unknown},
  title = {Tang J, Zhang Y, Yang L, Chen Q, Tan L, Zuo S, Feng H, Chen Z, Zhu G},
  year = {2015},
  doi = {10.1038/nature14129},
  
}
DOI: 10.1038/nature14129PubMed: 25631445

Quick Questions About This Study

HPV-associated head and neck tumors are dominated by PIK3CA helical domain mutations, TRAF3 loss, and E2F1 cell cycle gene amplification. These create a distinct genetic signature different from smoking-related cancers.
Smoking-related head and neck cancers show near-universal TP53 mutations and CDKN2A inactivation, plus frequent DNA copy number changes including 3q26/28 and 11q13/22 amplifications. This creates a characteristic genetic damage pattern.
A subgroup of oral cavity tumors with favorable outcomes had infrequent DNA copy number alterations combined with HRAS or PIK3CA activating mutations, plus CASP8, NOTCH1, and TP53 inactivating mutations.
Laryngeal tumors mainly showed loss-of-function changes in chromatin modifier NSD1, WNT pathway genes AJUBA and FAT1, and activation of oxidative stress factor NFE2L2. These patterns were distinct from other head and neck sites.
Yes, the study identified therapeutic candidate alterations in most of the 279 head and neck squamous cell carcinomas analyzed, suggesting potential treatment approaches based on each tumor's specific genetic profile.